Long-term prognosis of patients with Brugada syndrome and an implanted cardioverter-defibrillator

被引:6
作者
Dores, Helder [1 ]
Santos, Katya Reis [2 ]
Adragao, Pedro [1 ]
Costa, Francisco Moscoso [1 ]
Santos, Pedro Galvao [1 ]
Carmo, Pedro [1 ]
Cavaco, Diogo [1 ]
Morgado, Francisco Bello [1 ]
Mendes, Miguel [1 ]
机构
[1] Hosp Santa Cruz, Ctr Hosp Lisboa Ocidental, Serv Cardiol, Carnaxide, Portugal
[2] Hosp Luz, Ctr Cardiovasc, Lisbon, Portugal
关键词
Brugada syndrome; Implantable cardioverter-defibrillator; Prognosis; Syncope; Sudden cardiac death; Appropriate shocks; ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; SUDDEN CARDIAC DEATH; FOLLOW-UP; ELECTROCARDIOGRAPHIC PATTERN; RISK STRATIFICATION; INDIVIDUALS; PREVALENCE; THERAPY; DETERMINANTS;
D O I
10.1016/j.repc.2014.12.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Risk stratification of Brugada syndrome (BrS) remains controversial and recommendations for an implantable cardioverter-defibrillator (ICD) are not well established. The objective of this study was to assess the long-term prognosis of BrS patients with an ICD. Methods and Results: Of 55 consecutive patients with BrS assessed between April 2002 and October 2012, 36 (mean age 41.7 +/- 13.8 years; 81.8% male) underwent ICD implantation. Nineteen (52.8%) were asymptomatic, 11 (30.6%) had previous history of syncope (arrhythmic cause suspected in eight) and six (16.7%) had aborted sudden cardiac death (SCD). Spontaneous type 1 electrocardiographic (ECG) pattern was present in 25 (69.4%) patients and electrophysiological study (EPS), performed in 26 (72.2%), was positive in 22 (84.6%). During a mean follow-up of 74 +/- 40 months (>5 years in 72% of cases), seven (19.4%) patients had appropriate shocks (annual event rate 2.8%). These patients most frequently had aborted SCD (54.1% vs. 6.9%; p=0.008) and nonsustained ventricular tachycardia (57.1% vs. 10.3%; p=0.016) during follow-up. Spontaneous type 1 ECG pattern, syncope and positive EPS were not significantly associated with appropriate shocks. Multivariate analysis revealed that aborted SCD was an independent predictor of appropriate shocks (HR 8.07, 95% CI 1.58-41.2; p=0.012). ROC curve analysis demonstrated that aborted SCD had moderate discriminatory power to predict appropriate shocks (AUC 0.751), with sensitivity of 57% and specificity of 93%. In terms of ICD-related complications, eight (22.2%) patients had inappropriate shocks during the follow-up period, mainly due to sinus tachycardia (five patients); one patient had lead infection and another had a lead fracture. Conclusion: In this population of BrS patients with ICD, the long-term rate of appropriate shocks was 2.8%/year. Aborted SCD was associated with a higher risk of appropriate shocks, where as syncope and spontaneous type I ECG pattern did not predict this event. (C) 2014 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:394 / 401
页数:8
相关论文
共 50 条
  • [41] Long-term prognosis and emergency management for patients with an implantable cardioverter defibrillator: the EMERGE-ICD study
    Suero, Coral
    Martin, Alfonso
    Coll-Vinent, Blanca
    Gonzalez-Torrecilla, Esteban
    Ormaetxe, Jose
    Alvarez, Miguel
    del Arco, Carmen
    Cancio, Manuel
    Varona, Mercedes
    Sanchez, Susana
    Sanchez, Juan
    Fernandez-Lozano, Ignacio
    Arribas, Fernando
    Martin-Mendez, Maria
    Peinado, Rafael
    EMERGENCIAS, 2023, 35 (03): : 185 - 195
  • [42] Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT
    Poole, Jeanne E.
    Olshansky, Brian
    Mark, Daniel B.
    Anderson, Jill
    Johnson, George
    Hellkamp, Anne S.
    Davidson-Ray, Linda
    Fishbein, Daniel P.
    Boineau, Robin E.
    Anstrom, Kevin J.
    Reinhall, Per G.
    Packer, Douglas L.
    Lee, Kerry L.
    Bardy, Gust H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (04) : 405 - 415
  • [43] Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death
    Boule, Stephane
    Semichon, Marc
    Guedon-Moreau, Laurence
    Drumez, Elodie
    Kouakam, Claude
    Marquie, Christelle
    Brigadeau, Francois
    Kacet, Salem
    Potelle, Charlotte
    Escande, William
    Souissi, Zouheir
    Lacroix, Dominique
    Duhamel, Alain
    Klug, Didier
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2016, 109 (10) : 517 - 526
  • [44] Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome A Multicenter Study-Part 2
    Sacher, Frederic
    Probst, Vincent
    Maury, Philippe
    Babuty, Dominique
    Mansourati, Jacques
    Komatsu, Yuki
    Marquie, Christelle
    Rosa, Antonio
    Diallo, Abou
    Cassagneau, Romain
    Loizeau, Claire
    Martins, Raphael
    Field, Michael E.
    Derval, Nicolas
    Miyazaki, Shinsuke
    Denis, Arnaud
    Nogami, Akihiko
    Ritter, Philippe
    Gourraud, Jean-Baptiste
    Ploux, Sylvain
    Rollin, Anne
    Zemmoura, Adlane
    Lamaison, Dominique
    Bordachar, Pierre
    Pierre, Bertrand
    Jais, Pierre
    Pasquic, Jean-Luc
    Hocini, Meleze
    Legal, Francois
    Defaye, Pascal
    Boveda, Serge
    Iesaka, Yoshito
    Mabo, Philippe
    Haissaguerre, Michel
    CIRCULATION, 2013, 128 (16) : 1739 - 1747
  • [45] The psychological impact of implantable cardioverter defibrillator implantation on Brugada syndrome patients
    Probst, Vincent
    Plassard-Kerdoncuf, Delphine
    Mansourati, Jacques
    Mabo, Philippe
    Sacher, Frederic
    Fruchet, Christine
    Babuty, Dominique
    Lande, Gilles
    Guyomarc'h, Beatrice
    Le Marec, Herve
    EUROPACE, 2011, 13 (07): : 1034 - 1039
  • [46] Long-Term Outcomes Among a Nationwide Cohort of Patients Using an Implantable Cardioverter-Defibrillator: UMBRELLA Study Final Results
    Briongos-Figuero, Sem
    Garcia-Alberola, Arcadio
    Rubio, Jeronimo
    Segura, Jose Maria
    Rodriguez, Anibal
    Peinado, Rafael
    Alzueta, Javier
    Martinez-Ferrer, Jose B.
    Vinolas, Xavier
    Fernandez de la Concha, Joaquin
    Anguera, Ignasi
    Martin, Maria
    Cerda, Laia
    Perez, Luisa
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (01): : 1 - 23
  • [47] Long-Term Trends in Newly Diagnosed Brugada Syndrome Implications for Risk Stratification
    Casado-Arroyo, Ruben
    Berne, Paola
    Yoganarasimha, Jayakeerthi
    Rodriguez-Manero, Moises
    Levinstein, Moises
    Conte, Giulio
    Sieira, Juan
    Namdar, Mehdi
    Ricciardi, Danilo
    Chierchia, Gian-Battista
    de Asmundis, Carlo
    Pappaert, Gudrun
    La Meir, Mark
    Wellens, Francis
    Brugada, Josep
    Brugada, Pedro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (06) : 614 - 623
  • [48] The Wearable Cardioverter-Defibrillator: Experience in 153 Patients and a Long-Term Follow-Up
    Rosenkaimer, Stephanie L.
    El-Battrawy, Ibrahim
    Dreher, Tobias C.
    Gerhards, Stefan
    Roeger, Susanne
    Kuschyk, Juergen
    Borggrefe, Martin
    Akin, Ibrahim
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [49] Predicting long-term survival after de novo cardioverter-defibrillator implantation for primary prevention: A population based study
    Wang, Chang Nancy
    Lu, Zihang
    Simpson, Christopher S.
    Lee, Douglas S.
    Tranmer, Joan E.
    HELIYON, 2024, 10 (01)
  • [50] Propofol for implantable cardioverter defibrillator implantation in patients with Brugada syndrome
    Kwon, Hye-Mee
    Kim, Sung-Hoon
    Park, Se-Ung
    Rhim, Jin-Ho
    Park, Hee-Sun
    Kim, Wook-Jong
    Nam, Gi-Byoung
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2018, 41 (06): : 656 - 660